A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. (Q40474654)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. |
scientific article |
Statements
1 reference
A randomized, open-label, multicenter comparative study of the efficacy and safety of piperacillin-tazobactam and cefepime for the empirical treatment of febrile neutropenic episodes in patients with hematologic malignancies. (English)
1 reference
E J Bow
1 reference
C Rotstein
1 reference
G A Noskin
1 reference
M Laverdiere
1 reference
A P Schwarer
1 reference
B H Segal
1 reference
J F Seymour
1 reference
S Sanche
1 reference
10 July 2006
1 reference
1 reference
Identifiers
1 reference